Abeona Therapeutics (ABEO) – Analyst EPS View
-
Abeona Therapeutics (ABEO) PT Lowered to $29 at Cantor Fitzgerald; Maintains Buy
-
Maxim Group Reiterates Buy Rating and $14 PT on Abeona Therapeutics (ABEO) Ahead of ABO-102 Incremental Data Presentation on 4/11
-
Back to ABEO Stock Lookup